Daylight®

Overview

Medical condition:

Generalized anxiety disorder

Target patient population:

Patients who desire lasting recovery from anxiety

What to expect:

Daylight helped 71% of patients achieve clinical improvement in anxiety.

Note: for more information, please visit https://www.bighealth.com/daylight/.

Clinical Overview

Indications for use:

Daylight is a digital therapeutic intended for the improvement of worry and anxiety and the management of Generalized Anxiety Disorder (GAD) in adults aged 18 years and older, as an adjunct to their usual medical care. For adults diagnosed with GAD, Daylight should be used under the supervision of a healthcare professional. For otherwise healthy adults who have difficulty with worry and anxiety, Daylight may be used as a non-prescription self-help tool to improve overall mental health and wellbeing.

Outcomes:

Daylight helped 71% of patients achieve clinical improvement in anxiety.

Directions:

Users can spend as little as 10 minutes per day with Daylight’s structured, guided techniques, and see improvements within weeks. Daylight’s lessons can be paused or restarted by the user whenever needed.

Through this 10 minute per day commitment, users will build life-long skills to reduce tension, re-frame anxious thoughts, and develop helpful behaviors. And Daylight keeps the user on track by giving suggestions based on their individual needs, and checking in with them to guide progress.

Risks & warnings:

Daylight may not be suitable for people without internet, wifi, or a mobile device. Daylight is a digital therapeutic intended for the improvement of worry and anxiety and the management of generalized anxiety disorder (GAD) in adults aged 18 years and older, as an adjunct to their usual medical care.

Place in therapy:

Complementary to current therapy and effective as a standalone solution.

Product Access

Product description:

Daylight is a digital therapeutic for managing anxiety. It’s based on proven cognitive behavioral therapy and is developed by clinical psychologists and researchers. By spending just 10 minutes per day with Daylight’s structured, responsive program, you could see improvements within a few weeks – in trials, 71% of participants recovered from clinical levels of anxiety in 10 weeks.

Prescription status:

No prescription is required.

Patient access:

Eligible users can download the Daylight app on iOS or Android devices.

Use of this product requires access to:

• Internet or wifi
• a mobile phone, tablet, or computer

Provider access:

Daylight provides a non-drug alternative for anxiety without needing a prescription. In the UK, Daylight is available for eligible individuals through self-referral or by visiting their GP.

Coverage options:

In the US, Daylight is offered through large payers including self-insured employers. Daylight is offered to millions of people in the UK through their NHS services.

Product availability:

Daylight is available in:

• USA: FDA enforcement discretion
• UK: Class I CE mark

Clinical Trials

The provided set of evidence represents a sample of conducted studies. For a comprehensive collection contact manufacturers directly.

• Study Title: Efficacy of digital cognitive behavioral therapy for moderate-to-severe symptoms of generalized anxiety disorder: A randomized controlled trial – Carl et al., 2020
  Study Design: Randomized controlled trial
  Outcomes: 71% of participants achieved clinical improvement in anxiety.
• Study Title: Feasibility and efficacy of a digital CBT intervention for symptoms of Generalized Anxiety Disorder: A randomized multiple-baseline study – Miller et al., 2021
  Study Design: Single-case experimental design
  Outcomes: Over 70% of participants experienced clinical improvement in anxiety

Note: for more research, please visit https://www.bighealth.com/research/.